trevena.com (TRVN) - Uzoq muddatli majburiyatlarning kapitalga nisbati

trevena.com - TRVN emitenti grafik logotipi

Trevena, Inc. (TRVN) suveren rivojlanish siklining himoya xususiyatlaridan foydalangan holda, markaziy nerv tizimi (CNS) buzilishlari uchun ilg'or terapiya usullarini ishlab chiqadi. Indikator 0.00 qiymatida bo'lgan ushbu narx harakati grafigi G'arb zavodlaridagi ishlab chiqarishni autsorsing qilish modelini geosiyosiy to'siqlar bilan bog'laydi. Ushbu to'siqlar xalqaro sinovlar va biosimplalarni yetkazib berishni cheklab, kompaniyaning yangi mahsulotlari sertifikatsiyasini sezilarli darajada sekinlashtirmoqda.

Trevena Inc. (TRVN): Uzoq muddatli qarzning o'z kapitaliga nisbati 04.07.2022dan 19.10.2024gacha

Trevena, Inc. (TRVN) kompaniyasining tahliliy kesimlari

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Aksiya kursi Trevena Inc.|TRVN - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi ko'rsatkichlari:
Bozor qiymati Trevena, Inc.|TRVN - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- xususiy kapitalning balans qiymati ko'rsatkichlari:
Bitta aksiya hisobiga balans qiymati Trevena|TRVN - Kompaniyaning balans qiymati|Balans qiymatiga nisbatan bozor qiymati trevena.com|TRVN - Kompaniyaning jami aktivlari
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati Trevena, Inc.|TRVN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli kreditlarning kapitalga nisbati trevena.com|TRVN - Kompaniya qarzlari|Qarzning sof aktivlarga nisbati Trevena, Inc.|TRVN - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Trevena|Tezkor likvidlik trevena.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
TRVN - Sof foyda
Kompaniyaning har tomonlama tahlili:Trevena Inc. - TRVN
Trevena Inc original mahsuloti

Ushbu koeffitsiyent kompaniya kapitaliga nisbatan uzoq muddatli majburiyatlarning ulushini aks ettiradi. U biznesning aktivlarni shakllantirishda tashqi qarz moliyalashtirishga qanchalik tayanishini o'lchaydi. Uzoq muddatli qarz qoplash koeffitsiyentini tahlil qilish balans strukturasining barqarorligini baholash imkonini beradi. Trevena, Inc. uchun savdo tushrukvlarining yo'qligi ushbu ko'rsatkichni kritik qiladi. Naqd pul yetishmovchiligi va listingdan chiqarilish holatida, ushbu metrika likvidlikning butunlay yo'qolish xavfini namoyish etadi.

Muhim raqobatchilar

Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BIIB (Biogen Inc)|Uzoq muddatli qarzning kapitalga nisbati NBIX|RGC - Uzoq muddatli majburiyatlarning kapitalga nisbati|Axsome Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati acadia-pharm.com ACAD|XENE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti VKTX (Viking Therapeutics Inc)|Supernus Pharma (SUPN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Catalyst Corp (CPRX)|Uzoq muddatli qarzning o'z kapitaliga nisbati DNLI|HRMY (harmonybiosciences.com) - Uzoq muddatli kreditlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Biohaven (BHVN)|AMLX (Amylyx Pharmaceuticals Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati TRVI (Trevi Pharma)|Praxis Corp (PRAX) - Uzoq muddatli majburiyatlarning kapitalga nisbati|AVXL: Uzoq muddatli qarzning o'z kapitaliga nisbati|CBLL: Uzoq muddatli qarzning o'z kapitaliga nisbati|PRTA: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Alector (ALEC)|Uzoq muddatli qarzning o'z kapitaliga nisbati Annexon Inc.|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi OMER (Omeros Corp.)|Uzoq muddatli qarzning kapitalga nisbati NGNE|Uzoq muddatli qarzning kapitalga nisbati acimmune.com (ACIU)|Voyager Therapeutics, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti NMRA|Scilex Holding Co. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Tevogen Bio Inc. TVGN|alphacognition.com (ACOG) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi CGTX|IKT (Inhibikase Therapeutics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Cassava Sciences Inc (SAVA)|Uzoq muddatli qarzning o'z kapitaliga nisbati ASRT (Assertio Holdings, Inc.)|Uzoq muddatli qarzdorlikning kapitalga nisbati coyatherapeutics.com|Vistagen - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli kreditlarning kapitalga nisbati OVID (Ovid Therapeutics Inc)|ABOS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti CRVO (CervoMed, Inc.)|ATHE (alteritytherapeutics.com) - Uzoq muddatli qarzning o'z kapitaliga nisbati|CLNN (Clene) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati PepGen Inc|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi JUNS (jupiterneurosciences.com)|Uzoq muddatli qarzning o'z kapitaliga nisbati Relmada Therapeutics, Inc. (RLMD)|Annovis Bio Inc - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati GRCE (Grace Therapeutics)|Firefly Neuro (AIFF) - Uzoq muddatli majburiyatlarning kapitalga nisbati|KLTO: Uzoq muddatli qarzning o'z kapitaliga nisbati|NRSN - Uzoq muddatli qarzning kapitalga nisbati|Reviva Pharmaceuticals Holdings, Inc. (RVPH) - Uzoq muddatli qarzning o'z kapitaliga nisbati|MetaVia - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati NeurAxis, Inc|Uzoq muddatli majburiyatlarning kapitalga nisbati Helius Medical Technologies Inc. HSDT|Uzoq muddatli qarzning o'z kapitaliga nisbati PASG (Passage Bio, Inc.)|Uzoq muddatli kreditlarning kapitalga nisbati NEUP|Uzoq muddatli qarzning o'z kapitaliga nisbati Minerva Neurosciences, Inc. NERV|Uzoq muddatli qarzning kapitalga koeffitsiyenti ATHA|Addex Therapeutics, Ltd. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Alzamend Neuro, Inc.|CYCN (cyclerion.com) - Uzoq muddatli qarzning o'z kapitaliga nisbati|PTIX (Protagenic Therapeutics, Inc.) - Uzoq muddatli qarzning o'z kapitaliga nisbati|KTTA (Pasithea Therapeutics Corp) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Cortigent Medical CRGT|Uzoq muddatli qarzning o'z kapitaliga nisbati Avenue Therapeutics, Inc (ATXI)|BrainStorm Cell Therapeutics Inc. - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati CARA (Cara Therapeutics, Inc.)|Uzoq muddatli qarzning kapitalga nisbati chromocell.com CHRO|ELYM: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti ITCI (Intra-Cellular Therapies)|LBPH: Uzoq muddatli qarzning kapitalga nisbati|MRNS - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati NKGen Biotech, Inc.|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi NRBO (neurobopharma.com)|Uzoq muddatli qarzning kapitalga nisbati SAGE|Uzoq muddatli qarzning o'z kapitaliga nisbati Synaptogenix Inc. SNPX|Vigil Neuroscience, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Anew Medical Inc. (WENA)|CERE: Uzoq muddatli qarzning o'z kapitaliga nisbati